Google Inc’s ambitious health startup Calico is teaming up with biotechnology drugmaker AbbVie Inc in a US$500 million joint venture that is set to try and develop new ways to treat cancer and other diseases such as Alzheimer’s.
The alliance announced on Wednesday calls for Google and AbbVie to each invest US$250 million in the project. An additional US$1 billion might be poured into the project. The two companies are to split all expenses and any profits generated by the venture.
Calico, a company created by Google last year, is to manage a team of scientists who are to work at a research-and-development laboratory in the San Francisco Bay Area. The precise location and size of the new laboratory has not been determined.
AbbVie, a spin-off from Abbott Laboratories, is to oversee the marketing of the drugs. The company has already been working on drugs to fight Parkinson’s disease, Crohn’s disease and other ailments.
Google set up Calico as a separate business last year to pursue medical breakthroughs that would enable people to live longer. Toward that end, Calico is doing extensive research to get a better understanding of how the human body ages and working on technology that could cure cancer.
Calico is run by Arthur Levinson, a former chief executive officer of biotech pioneer Genentech and a former member of Google’s board. He is also the chairman of Apple Inc, which is expected to provide further details to help people manage their health next week when the company unveils its latest iPhone.
The expansion into health might also include a new Apple device that could be worn on a person’s wrist.
PERSISTENT RUMORS: Nvidia’s CEO said the firm is not in talks to sell AI chips to China, but he would welcome a change in US policy barring the activity Nvidia Corp CEO Jensen Huang (黃仁勳) said his company is not in discussions to sell its Blackwell artificial intelligence (AI) chips to Chinese firms, waving off speculation it is trying to engineer a return to the world’s largest semiconductor market. Huang, who arrived in Taiwan yesterday ahead of meetings with longtime partner Taiwan Semiconductor Manufacturing Co (TSMC, 台積電), took the opportunity to clarify recent comments about the US-China AI race. The Nvidia head caused a stir in an interview this week with the Financial Times, in which he was quoted as saying “China will win” the AI race. Huang yesterday said
Japanese technology giant Softbank Group Corp said Tuesday it has sold its stake in Nvidia Corp, raising US$5.8 billion to pour into other investments. It also reported its profit nearly tripled in the first half of this fiscal year from a year earlier. Tokyo-based Softbank said it sold the stake in Silicon Vally-based Nvidia last month, a move that reflects its shift in focus to OpenAI, owner of the artificial intelligence (AI) chatbot ChatGPT. Softbank reported its profit in the April-to-September period soared to about 2.5 trillion yen (about US$13 billion). Its sales for the six month period rose 7.7 percent year-on-year
Nissan Motor Co has agreed to sell its global headquarters in Yokohama for ¥97 billion (US$630 million) to a group sponsored by Taiwanese autoparts maker Minth Group (敏實集團), as the struggling automaker seeks to shore up its financial position. The acquisition is led by a special purchase company managed by KJR Management Ltd, a Japanese real-estate unit of private equity giant KKR & Co, people familiar with the matter said. KJR said it would act as asset manager together with Mizuho Real Estate Management Co. Nissan is undergoing a broad cost-cutting campaign by eliminating jobs and shuttering plants as it grapples
MORE WEIGHT: The national weighting was raised in one index while holding steady in two others, while several companies rose or fell in prominence MSCI Inc, a global index provider, has raised Taiwan’s weighting in one of its major indices and left the country’s weighting unchanged in two other indices after a regular index review. In a statement released on Thursday, MSCI said it has upgraded Taiwan’s weighting in the MSCI All-Country World Index by 0.02 percentage points to 2.25 percent, while maintaining the weighting in the MSCI Emerging Markets Index, the most closely watched by foreign institutional investors, at 20.46 percent. Additionally, the index provider has left Taiwan’s weighting in the MSCI All-Country Asia ex-Japan Index unchanged at 23.15 percent. The latest index adjustments are to